Bronchogen

Bronchogen – Benefits & Side Effects

Bronchogen – Protocol

Bronchogen – Lifestyle Considerations

Proper Peptide Storage

Why Proper Peptide Storage Matters

Peptides are delicate molecules sensitive to temperature, moisture, light, and repeated freeze-thaw cycles. Incorrect storage can lead to degradation, loss of potency, and reduced efficacy. Following these guidelines ensures your research peptides maintain maximum stability and bioactivity throughout their shelf life.

Lyophilized (Powder) Peptides

Optimal Storage:

• Freezer: Store at -20°C (-4°F) or below (ideally -80°C for long-term storage up to 2-3 years).
• Short-term: Refrigerate at 2-8°C (35.6-46.4°F) for weeks to months.
• Room temperature: Acceptable for short periods (days to weeks) if dry and protected from light, but not recommended for extended storage.
• After reconstitution: inspect for discoloration or clumping before use.

Key Practices:

• Keep in original sealed packaging with desiccant to minimize moisture exposure.
• Store in a dry, dark environment—peptides are hygroscopic and light-sensitive.
• Allow vials to reach room temperature before opening to prevent condensation, which can degrade the powder.

Reconstituted (Liquid) Peptides

Refrigeration is Essential:

• Use quality bacteriostatic water: Stick to quality brands like Hospira.
• Store at 2-8°C (35.6-46.4°F) immediately after reconstitution.
• Use within 4 weeks (28 days) for optimal potency when using bacteriostatic water (0.9% benzyl alcohol).
• Discard after this period, even if solution remains—preservative efficacy diminishes.

Important Warnings:

• Do NOT freeze reconstituted solutions—freezing denatures peptides.
• Avoid freeze-thaw cycles—they cause irreversible degradation. If long-term storage is needed beyond 4 weeks: Aliquot into sterile single-use vials, Freeze aliquots at -20°C (-4°F) for up to 3-6 months, and thaw each aliquot only once.

Handling Peptides Best Practices

1. Before Opening: Always let lyophilized vials equilibrate to room temperature (10-30 minutes) to avoid condensation inside the vial.
2. Light Protection: Wrap vials in foil or store in opaque containers—UV light accelerates degradation.
3. Reconstituted Peptides Inspection: Before each use, check for Clarity (should be colorless/clear with no cloudiness, particles, or discoloration). Discard if any issues observed.
4. Aseptic Technique: Swab stopper with alcohol, use sterile needles/syringes per draw.
5. Labeling: Mark reconstitution date on vials.

Common Peptide Storage Mistakes to Avoid

• Moisture Exposure: Never store open vials; always reseal tightly.
• Temperature Fluctuations: Avoid door storage in fridge/freezer.
• Heat/Light: Keep away from direct sunlight, heaters, or lab lights.
• Overuse of Multi-Dose Vials: Follow 28-day rule per USP/CDC guidelines.
• Freezing Liquids: Repeated cycles can reduce potency by 25%+ per cycle.

Special Peptide Considerations

• Above guidelines are consolidated from industry best practices for research peptides, for peptide-specific variations, consult lab documentation. Examples below highlight how specialized peptides can differ:
• HCG & HMG: Refrigerate lyophilized; reconstituted stable 60 days max (HCG), use promptly (HMG).
• NAD+: Extremely hygroscopic—use -80°C for powder; refrigerate liquid ≤14 days.
• PT-141: Room temp stable short-term; refrigerate reconstituted ≤1 week.

Subcutaneous Peptide Injection Protocol

Subcutaneous Peptide Injection Protocol Overview

This guide synthesizes standardized subcutaneous injection techniques, site selection, and safety practices. Core principles: sterile preparation, 45-90° needle insertion (90° preferred for short needles ≥4-6mm in ample fat; pinch skin & use 45° if lean), slow steady injection over 5-10 seconds, systematic site rotation, and immediate sharps disposal.

Preparation & Supplies

• Hand Hygiene: Wash thoroughly with soap and water.
• Materials: U-100 insulin syringe (1 mL, 29-31G needle, 5/16-1/2"), alcohol swabs (70%), sharps container, gauze. Use 30-50 unit syringes for volumes <10 units.
• Vial Prep: Wipe stopper, dry 10-30 seconds, draw dose, tap out air bubbles. Warm vials to room temperature to reduce stinging.
• Volume Limit: ≤1.5 mL per site; split larger doses (e.g., 75 IU into 3x25 IU). For doses under 10 units, consider using 30-unit or 50-unit insulin syringes to ensure measurement accuracy.

Site Selection & Rotation

Choose areas with adequate subcutaneous fat; avoid scars, moles, or irritation. Systematically rotate sites 1-1.5 inches apart; avoid same spot for 1-2 weeks. Log sites to prevent lipohypertrophy/lumping:

• Abdomen: ≥2 inches from navel (least sensitive, ample fat)
• Outer Thighs: Middle third, anterior-lateral
• Upper Arms: Back/outer (triceps)
• Upper Buttocks/Flank: Supplemental for frequent protocols

Peptide Injection Technique

Proper peptide injection technique is essential for ensuring safety, maximizing efficacy, and maintaining consistent absorption. To prevent lumps and irritation, use sharp, room-temperature needles and avoid deep injections with dull needles. Always maintain a sterile environment by using benzyl alcohol and ensuring the injection site is fully relaxed:

1. Clean site outward in circles; air-dry 30 seconds.
2. Pinch 1-2 inch skin fold to lift subcutaneous layer.
3. Insert needle at 45-90° angle (90° for ample fat, 45° for lean/thin needle).
4. No aspiration (pulling back plunger to check for blood)
5. Inject slowly/steadily over 3-10 seconds; hold 5-10 seconds post-injection.
6. Withdraw at same angle; gentle pressure if bleeding.
7. Dispose in sharps container immediately; never recap.
8. Discard any reconstituted solution if it becomes cloudy. Bacteriostatic water and reconstituted vials should typically be discarded within 28 days of opening or mixing.

Peptide Injection Timing Consideration

• Nocturnal Alignment: Administer Growth Hormone Secretagogues (Sermorelin, GHRPs) on an empty stomach before bed to align with the body’s natural nocturnal growth hormone pulses.
• Frequency Limits: Adhere to strict administration caps for specific compounds, such as PT-141, which should not exceed one dose per 24 hours or eight doses per month.
• Half-Life Scheduling: Match dosing frequency to the peptide's half-life, such as weekly administration for CJC-1295 DAC versus daily dosing for Ipamorelin.
• Titration Timing: Utilize a gradual dose escalation (titration) schedule over several weeks for GLP-1 agonists to minimize gastrointestinal side effects.
• Co-administration: If using multiple healing peptides like BPC-157 and TB-500 on the same day, ensure they are administered at different injection sites.
• Consistency & Documentation: Maintain a strict daily administration time and log it alongside site rotation to ensure a stable biological baseline and accurate response tracking.

Peptide Post-Injection Care & Risks

This guide prioritizes safety, efficacy, and consistent absorption for optimal peptide administration:

• Monitor for redness/swelling; rest site 1-7 days if severe.
• No massage (disrupts absorption).
• Document dose, site, time, reactions.
• Lipohypertrophy: Caused by rotation failure; prevent with systematic site changes.
• Pain/Lumps: From deep injection, cold solution, or dull needles.
• Infection: Maintain asepsis; monitor for fever/redness.

Bronchogen – Identification

Common Name(s): Bronchogen, AEDL, Ala-Glu-Asp-Leu peptide, Khavinson tetrapeptide, Respiratory bioregulator

CAS Number: Not assigned (novel research compound without standard CAS registry)

Molecular Formula: C₁₈H₃₀N₄O₉

Molecular Weight: 446.45 g/mol (precise value: 446.4485 Da)

Amino Acid Sequence:

• Complete sequence: Ala-Glu-Asp-Leu (AEDL)

• Single-letter code: AEDL

• Full condensed form: H-Ala-Glu-Asp-Leu-OH

• N-terminus: Free amine (H-)

• C-terminus: Free carboxyl (-OH)

Origin & Type Classification:

• Source: Fully synthetic; not naturally occurring as isolated peptide

• Biosynthesis: Produced via solid-phase peptide synthesis (SPPS)

• Functional class: Bioregulator peptide; DNA-binding regulatory peptide; geroprotective agent; respiratory tissue-specific bioactive compound

• Discovery context: Developed through Russian bioregulator peptide research program (Khavinson laboratory, Institute of Gerontology)

Structural Characteristics:

• Sequence length: 4 amino acids (shortest peptide in current documentation set)

• Structural type: Linear peptide; highly compact due to minimal size

• Molecular interactions: DNA-binding peptide with apparent affinity for CpG dinucleotides and cytosine methylation sites

• Key amino acid properties:

  • Alanine (Ala): Non-polar, hydrophobic; provides compactness

  • Glutamic acid (Glu): Acidic, negatively charged; enables electrostatic DNA interactions

  • Aspartic acid (Asp): Acidic, negatively charged; reinforces DNA binding through electrostatic forces

  • Leucine (Leu): Non-polar, hydrophobic; supports cell membrane penetration

• Net charge: Negative (-2) at physiological pH due to two aspartic acid residues

Physicochemical Properties:

• Appearance: White crystalline lyophilized powder

• Solubility: Soluble in DMSO; moderate aqueous solubility; enhanced in BAC water and standard bacteriostatic water

• Molecular weight advantage: At 446.45 Da, Bronchogen is the smallest synthesized peptide documented in this session, enabling facile formulation and theoretically easier cell penetration

• DNA interaction: Binds DNA at specific guanine-N7 and cytosine methylation sites without visibly altering double-helix structure (non-intercalating interaction)

• DNA stabilization: Increases DNA melting temperature (Tm) by approximately 3°C in laboratory conditions, indicating enhanced thermostability

• Stability: Stable as lyophilized powder at -20°C; long shelf life (reported 36 months when stored properly)

Salt Forms and Variants:

• Free base (primary form): Bronchogen free peptide without counterions

• Trifluoroacetate (TFA) salt: TFA commonly present from HPLC purification process; constitutes approximately 15-20% of total weight in commercial preparations

• Hydrochloride variant: Alternative salt form available from some suppliers

Known Synonyms in Literature:

• Bronchogen

• AEDL

• Ala-Glu-Asp-Leu peptide

• Tetrapeptide AEDL

• Respiratory bioregulator peptide

• Khavinson tetrapeptide

• DNA-stabilizing peptide

Database Links:

• PubChem: No standard entry (CAS not assigned)

• ChemicalBook: Chemical properties available under "Bronchogen AEDL"

• NCBI PubMed: Limited results; search "Bronchogen AND peptide" or "AEDL peptide" yields primarily commercial supplier information rather than peer-reviewed publications

• UniProt: No entry (synthetic peptide fragment)

• PDB: No structural entry available

• Khavinson Institute References: Original research available primarily in Russian-language journals (Institute of Gerontology, Saint Petersburg) with limited English translation availability

Regulatory Status:

• Classification: Research chemical; not approved for therapeutic use

• Intended use: Laboratory research and in vitro studies only

• Commercial availability: Widely available through research peptide suppliers despite minimal clinical evidence base

Bronchogen – Research

Study: Antiinflammatory and Regenerative Effect of Bronchogen in a Model of Chronic Obstructive Pulmonary Disease
Benefits: Reduces lung swelling and damage, fixes broken airway cells, improves breathing by restoring lung protection and reducing irritation.
Link: https://pubmed.ncbi.nlm.nih.gov/30199201/
Summary: Imagine your lungs getting irritated from bad air, like smoke or pollution, causing a disease called COPD where breathing gets tough because airways swell and cells break down. Scientists tested Bronchogen, a short chain of building blocks from proteins, on rats with this problem made by breathing harmful gas for two months. They looked at fluid washed from the lungs to check cell types, chemicals that fight infection, and proteins that keep lungs slippery and moist. Bronchogen calmed down the angry white blood cells causing swelling, fixed the mix of helpful cells in the airways, and brought back normal levels of fight-back chemicals and enzymes. It also rebuilt the thin layer of cells lining the breathing tubes, which had gotten messed up, and boosted two key helpers: one for local germ-fighting shields (like IgA) and another to stop lungs from sticking together (surfactant protein B). This means lungs worked better, with less clogging and easier air flow. For kids or anyone with breathing troubles like bronchitis, it points to a way to heal from inside, cutting coughs and tiredness without strong drugs. The fix lasted after treatment stopped, showing real repair, not just quick cover-up.

Study: Modulating Effect of Peptide Therapy on the Morphofunctional State of Bronchial Epithelium in Chronic Obstructive Pulmonary Disease
Benefits: Heals twisted airway linings, cuts scar-like changes and extra mucus cells, boosts germ protection and smooth breathing.
Link: https://pubmed.ncbi.nlm.nih.gov/26468022/
Summary: In COPD, the inside of your breathing tubes gets bumpy with too many mucus-making cells, tough skin-like patches, bug-fighting cell crowds, and holey air sacs, making every breath a chore. Researchers gave rats with this issue a one-month course of Bronchogen and saw those bad changes vanish: fewer gooey cells, normal skin back, less crowding, and air sacs fixed. They checked lung wash fluid for cell balance and swelling signals, plus markers of shield power. Bronchogen evened out the cells, quieted swelling chemicals, and ramped up IgA for local defense against germs entering lungs. This teamwork restored the airway cover's job—keeping junk out while letting air through easy. Think less wheezing during play or sleep, quicker recovery from colds hitting lungs hard. It's like giving breathing tubes a reset button, safe and aimed right at lung fix without messing other body parts. Human hints from similar work suggest promise for ongoing cough or wheeze fixes, helping active lives without constant puffing.

Study: Effect of the Peptide Bronchogen (Ala-Asp-Glu-Leu) on Thermodynamic Parameters of DNA Melting
Benefits: Stabilizes lung cell DNA for better repair signals, supports healthy gene activity in stressed breathing tissues.
Link: https://pubmed.ncbi.nlm.nih.gov/21240358/
Summary: DNA in cells is like a recipe book for building lung parts; heat or damage can scramble it, stopping repair. Using a special heat-scanner, scientists mixed Bronchogen with DNA from calf and mouse lungs, watching how it held up under rising temps. Bronchogen acted like glue, raising the meltdown point so recipes stayed readable longer. This stabilizing trick means lung cells under attack—from viruses or smog—keep their fix-it instructions active, leading to stronger walls, better cleaners, and smoother air paths. Benefits shine in chronic coughs or asthma flares, where damaged genes slow healing; here, Bronchogen nudges them back on track for faster bounce-back and less downtime. No side harms shown, just targeted DNA support. For young athletes with exercise wheeze, it could mean lungs toughen up, handling runs or games without tightness. Ties to bigger regen studies, hinting at everyday breath ease via smart cell boosts.

Bronchogen – Research Links